 |
Jay S. Loeffler, MD, FACR—Activity Chair Herman & Joan Suit Professor of Radiation Oncology Harvard Medical School Chief, Department of Radiation Oncology Massachusetts General Hospital Boston, Massachusetts |
Jay S. Loeffler, an honors graduate of Williams College, completed a medical degree at Brown University School of Medicine. He completed his residency and chief residency at Harvard Medical School’s Joint Center for Radiation Therapy in Boston, and a postdoctoral research fellowship in the Department of Cancer Biology at the Harvard School of Public Health. Dr. Loeffler has been on the faculty at Harvard Medical School for 21 years.
Board certified in therapeutic radiology, Dr. Loeffler holds membership in several professional societies and advisory bodies. He serves on the Brain Tumor and Chemical Modifier and Tumor Biology Committees of the Radiation Therapy Oncology Group, the Medical Advisor Board of the Brain Tumor Society, the American Association of Neurological Surgeons Task Force on Therapeutic Neuroradiology, and the American Association of Neurological Surgeons and Congress of Neurological Surgeons Joint Section on Tumors. Additionally, Dr. Loeffler is Past President of the International Stereotactic Radiosurgery Society. Among his many awards, Dr. Loeffler was named a Leading Health Professionals of the World in 2006, Jacob Fabrikant Award, and he received the Team Award, Clinical Research Prize at the Massachusetts General Hospital Clinical Research Symposium in 2007.
Dr. Loeffler is an authority on the treatment of primary and malignant brain tumors and is a highly sought invited lecturer and visiting professor. He has published over 150 articles in peer-reviewed journals, edited 6 textbooks, and authored several review articles, editorials, and book chapters. Additionally, he serves on the editorial boards of International Journal of Radiation Oncology Biology and Physics, Neurosurgery, Nature Oncology, The Oncologist, Technology in Cancer Research and Treatment, and Journal of Neuro-Oncology. Dr. Loeffler was formerly the principal investigator on a large program project grant concerning proton therapy.
 |
Lawrence R. Kleinberg, MD Co-Director Stereotactic Radiosurgery Associate Professor of Radiation Oncology and Neurosurgery Department of Radiation Oncology and Molecular Radiation Sciences Johns Hopkins University Baltimore, Maryland |
Lawrence R. Kleinberg received a medical degree from Yale University School of Medicine in New Haven, Connecticut. He completed an internship in internal medicine at Mount Sinai Medical Center and a residency in radiation oncology at the Memorial Sloan-Kettering Cancer Center, both in New York City. Dr. Kleinberg also earned a Business of Health Care certificate at Johns Hopkins University in Baltimore, Maryland. Dr. Kleinberg has been on the faculty at Johns Hopkins University for 14 years.
Board certified in therapeutic radiology, Dr. Kleinberg holds membership in several professional societies, including the American Society for Therapeutic Radiology and Oncology, American Society for Clinical Oncology, and the Society for Neuro-Oncology. Additionally, he is Vice Chair of the Eastern Cooperative Oncology Group (ECOG) Brain Tumor Working Group and Coordinator of the ECOG GI Committee for Esophageal Protocol Development. Among Dr. Klienberg’s many honors are the Oncology Center Director’s Teaching Award for Excellence in Clinical Science (1998) and scholarship to the American Association for Cancer Research workshop, Accelerating Anticancer Agent Development and Validation (2004). Dr. Kleinberg is a Diplomate of the National Board of Medical Examiners.
Dr. Kleinberg has authored several book chapters and published numerous articles and abstracts in such peer-reviewed journals as Journal of Radiotherapy in Practice, Journal of Neuro-Oncology, and Journal of Clinical Oncology. Additionally, he is a reviewer for the Journal of Clinical Oncology and the International Journal of Radiation, Oncology, Biology, and Physics. Dr. Kleinberg has been a principal investigator in several studies of glioblastoma and adenocarcinoma. His research interests include testing new glioblastoma therapy agents, improving fractionated stereotactic radiosurgery for acoustic neuroma, and radiosurgery for multiple brain metastasis. Dr. Kleinberg is highly sought nationally and internationally as an invited lecturer.
 |
Dennis C. Shrieve, MD, PhD Professor and Chair, Department of Radiation Oncology Huntsman Cancer Institute University of Utah School of Medicine Salt Lake City, Utah |
Dennis C. Shrieve received a medical degree from the University of Miami and a doctorate in radiation biophysics from the University of California at Berkeley. He completed an internship in medicine and a residency (and chief residency) in radiation oncology at the University of California, San Francisco. Dr. Shrieve has served on the faculties of the University of California, San Francisco, and Harvard Medical School.
Board certified in radiation oncology, Dr. Shrieve holds membership in several professional societies, including the Radiation Research Society, American Association for Cancer Research, American College of Radiology, and the American Society for Therapeutic Radiology and Oncology. He is also a member of the National Space Biomedical Research Institute and the Brain Tumor Progress Review Group for the National Cancer Institute and the National Institute of Neurological Disorders and Stroke. He has received numerous young investigator awards, and he has been named on Castle Connolly Publishers’ "America's Top Doctors for Cancer" list (2005–2007).
Dr. Shrieve has authored 2 book chapters and published over 100 articles, letters, and reviews in peer-reviewed journals, including Cancer, International Journal of Radiation Oncology, Biology, Physics, and Journal of Neuro-Oncology. His primary clinical research interests include adult and pediatric neuro-oncology, pediatric radiation oncology, and conformal radiotherapy, and he has been a principal or co-principal investigator in several studies. His basic research interests include intrinsic radiosensitivity of human tumors, the mechanisms of intrinsic cellular resistance to radiation and chemotherapy, and combined chemotherapy/radiotherapy.